Voriconazole is a triazole-based antifungal agent used for the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. It is grouped under the following drug class(es): QTc-prolonging agents. Its therapeutic use is listed as anti-infectives, antifungals, dermatologicals and ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Voriconazole and Vfend. Its PubChem CID is 71616.
Voriconazole
| CAS No | 188416-29-7 |
|---|---|
| Molecular Formula | C16H14F3N5O |
| Molecular Weight | 349.31 g/mol |
| Synonyms | (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Voriconazole is a triazole-based antifungal agent used for the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp.
The listed CAS number is 188416-29-7.
The listed molecular formula is C16H14F3N5O.
The listed molecular weight is 349.31 g/mol.
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol.
The source lists Voriconazole and Vfend.